# A Study of NeoRecormon in Patients With Chronic Kidney Disease.

> **NCT00437723** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 90 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** epoetin beta [NeoRecormon]

## Key facts

- **NCT ID:** NCT00437723
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2008-04
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2009-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00437723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00437723, "A Study of NeoRecormon in Patients With Chronic Kidney Disease.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00437723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*